Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure
Author:
Funder
European Commission
Dutch Heart Foundation
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine
Reference35 articles.
1. Fibroblast growth factor-23: what we know, what we don't know, and what we need to know;Kovesdy;Nephrol. Dial. Transplant.,2013
2. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease;Isakova;JAMA,2011
3. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis;Gutierrez;N. Engl. J. Med.,2008
4. Fibroblast growth factor-23 and cardiovascular events in CKD;Scialla;J Am Soc Nephrol,2014
5. FGF23 induces left ventricular hypertrophy;Faul;J. Clin. Invest.,2011
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Renal Congestion in Heart Failure: Insights in Novel Diagnostic Modalities;Cardiology in Review;2024-02-29
2. Fibroblast Growth Factors in Cardiovascular Disease;Journal of Atherosclerosis and Thrombosis;2024
3. HFpEF: New biomarkers and their diagnostic and prognostic value;Current Problems in Cardiology;2024-01
4. NT‐proBNP Mediates the Association Between FGF23 and All‐Cause Mortality in Individuals With Type 2 Diabetes;Journal of the American Heart Association;2023-12-05
5. Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF;International Journal of Cardiology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3